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Abstract
Background: Persistent depressive symptoms below the threshold criteria for major depression represent a chronic
condition with high risk of progression to a diagnosis of major depression. The evidence base for psychological
treatments such as Person-Centred Counselling and Low-Intensity Cognitive Behavioural Therapy for sub-threshold
depressive symptoms and mild depression is limited, particularly for longer-term outcomes.
Methods: This study aimed to test the feasibility of delivering a randomised controlled trial into the clinical and
cost effectiveness of Low-Intensity Cognitive Behavioural Therapy versus Person-Centred Counselling for patients
with persistent sub-threshold depressive symptoms and mild depression. The primary outcome measures for this
pilot/feasibility trial were recruitment, adherence and retention rates at six months from baseline. An important
secondary outcome measure was recovery from, or prevention of, depression at six months assessed via a structured
clinical interview by an independent assessor blind to the participant’s treatment condition. Thirty-six patients were
recruited in five general practices and were randomised to either eight weekly sessions of person-centred counselling
each lasting up to an hour, or up to eight weeks of cognitive-behavioural self-help resources with guided telephone
support sessions lasting 20–30 minutes each.
Results: Recruitment rate in relation to the number of patients approached at the general practices was 1.8 %. Patients
attended an average of 5.5 sessions in both interventions. Retention rate for the 6-month follow-up assessments was
72.2 %. Of participants assessed at six months, 71.4 % of participants with a diagnosis of mild depression at baseline had
recovered, while 66.7 % with a diagnosis of persistent subthreshold depression at baseline had not developed
major depression. There were no significant differences between treatment groups for both recovery and
prevention of depression at six months or on any of the outcome measures.
Conclusions: It is feasible to recruit participants and successfully deliver both interventions in a primary care
setting to patients with subthreshold and mild depression; however recruiting requires significant input at the
general practices. The evidence from this study suggests that short-term Person-Centred Counselling and Low-Intensity
Cognitive Behaviour Therapy are potentially effective and their effectiveness should be evaluated in a larger randomised
controlled study which includes a health economic evaluation.
Trial registration: Current Controlled Trials ISRCTN60972025.
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Background
Depression is a major public health problem that is asso-
ciated with poor quality of life, impaired interpersonal
and family relationships, occupational disadvantage, re-
sidual disability, and suicide [1, 2]. Having persistent
depressive symptoms below the threshold criteria for
major depression is a chronic and disabling condition
with a high risk of progression [3, 4]. Depressive symp-
toms are considered ‘persistent’ if they have been present
for several months or continue despite active monitoring
by a clinician or low-intensity intervention [5].
Low-Intensity Cognitive Behavioural Therapy (Li-CBT),
involving guided self-help CBT interventions, has been
found to be an effective intervention for mild to moderate
depression compared with no treatment controls, with a
mean effect (Cohen’s d) of 0.8 [6]. Guided self-help CBT,
which is termed a low intensity (LI) intervention because
the amount of practitioner time is limited compared to
traditional high intensity (HI) expert-led treatments, can
be delivered through books, classes, computers and online
resources [7]. Expert delivered CBT and guided self-help
CBT showed equivalent outcomes for depression in a re-
cent meta-analysis of findings from randomised controlled
trials [8].
Person-centred counselling (PCC), also known as
Rogerian psychotherapy or non-directive counselling,
has been the most common psychological intervention
offered in community settings in the United Kingdom
(UK) [9]. PCC aims to provide an empathic, genuine,
and accepting therapeutic relationship that fosters cli-
ents’ inner capacities and resources, promoting positive
change [10]. A review of the effectiveness of counselling
in primary care found that counselling was superior to
standard General Practitioner (GP) care with an effect
size of 0.5 to 0.6, with the strongest effects in the short
term [11].
However, in spite of the two approaches being recom-
mended for mild to moderate depression in the UK by
the National Institute for Health and Care Excellence
(NICE) [5] there is no evidence of comparative effective-
ness of PCC and Li-CBT in patients with sub-threshold
and mild depression. Therefore, this study aimed to test
the feasibility of delivering a randomised controlled trial
(RCT) into the clinical and cost effectiveness of Low-
Intensity Cognitive Behaviour Therapy (Li-CBT) versus
Person-Centred Counselling (PCC) for patients with
persistent sub-threshold depressive symptoms and mild
depression.
Methods
This study was a two-arm, parallel group, pilot rando-
mised trial comparing short-term (six months) outcomes
of PCC and Li-CBT. It was approved by the West of
Scotland Research Ethics Service (WoSRES) at National
Health Service Greater Glasgow and Clyde (NHS GG&C),
REF: 12/WS/0173. This study is registered with Current
Controlled Trials (ISRCTN60972025) and the protocol
has been published [12].
Recruitment
Participants were identified and screened for eligibility at
five general practices in Glasgow (UK) according to re-
cruitment methods developed for the study [12]. Inclu-
sion criteria were: Age ≥ 16; scoring 5–18 on the Patient
Health Questionnaire (PHQ-9) [13] (i.e. mild or moder-
ate low mood) at screening; screened positive for persist-
ent (i.e. > 6 months) sub-threshold depressive symptoms
or mild depression (SCID) [14]; and capable of taking
part in research procedures, as assessed by the re-
searcher at baseline assessment. Exclusion criteria were:
Alcohol/substance dependence; receiving other psycho-
logical intervention; bipolar disorder; bereavement as the
presenting issue; Post-traumatic Stress Disorder (PTSD);
cognitive impairment; unable to understand, speak, read
or write in English; terminal illness; and unable to take
part in any of the interventions.
When patients arrived at the general practice, they re-
ceived a pack with study information and a self-report
measure for depression (PHQ-9) which they were asked
to complete. The pack also included a questionnaire
about reasons for not wanting to take part in the study.
Participants scoring 5–18 on the PHQ-9 (i.e. mild or
moderate depression) were considered potentially eligible
for the study. The list of potentially eligible participants
identified at the practice was subsequently checked by the
GP to identify anyone who met the exclusion criteria for
the study. Those potentially eligible participants, not
screened out by the GP, were invited to attend a baseline
assessment with a researcher. Eligibility to enter the trial
was then assessed by the researcher using a structured
clinical interview (SCID). We aimed to recruit 50 patients
into the pilot study.
Randomisation
At the end of the baseline assessment, all eligible and
consenting participants were randomly allocated by the
researcher to one of the two treatments through a re-
mote telephone randomisation system, after entering the
necessary baseline participant information. Randomisa-
tion was produced by a computer-generated code. The
use of an automated telephone randomisation system
ensured concealment of allocation. Participants were
randomised individually in blocks of four, stratified by
practice to balance practice level effects.
Interventions
Patients randomised to PCC were offered eight weekly,
50 min, sessions of person-centred counselling delivered
Freire et al. BMC Psychiatry  (2015) 15:197 Page 2 of 11
by qualified counsellors. At minimum, they had a
diploma-level training in PCC. A therapy manual was
designed specifically for this trial based on the Skills for
Health competence framework for Humanistic Psycho-
logical Therapies [15].
Patients randomised to Li-CBT received a range of
written CBT self-help booklets and worksheets [16]
supported by an optional linked online support course.
Participants received telephone support over a series of
up to eight support sessions lasting 20–40 min. Guid-
ance was delivered by trained support staff working with
a community charity organisation.
Outcome measures
Participants attended face-to-face assessments with a
researcher at baseline, 3 and 6 month follow-ups.
The primary outcome measures of the study were
recruitment, adherence and retention rates at six months
from baseline. Secondary outcome measures were: (1)
changes at 6 months on the GRID Hamilton Depression
Rating Scale (GRID-HAMD-17) [17]; (2) recovery from,
or prevention of, depression according to DSM-IV
(Diagnostic and Statistical Manual of Mental Disorders,
fourth edition) [18] diagnosis at 6 months assessed via
the Structured Clinical Interview for DSM-IV (SCID);
(3) changes at 6 months on the Patient Health Question-
naire–9 (PHQ-9), Work and Social Adjustment Scale
(WSAS) [19], Euroquol (EQ-5D-5 L) [20], and SF12v2
MH Enhanced [21]. Participants were also asked to
complete the Client Satisfaction Questionnaire (CSQ-8)
[22] at 3-month follow-up assessment. The 6-month
follow-up assessments were carried out by an independ-
ent assessor blind to the participant’s treatment.
The feasibility of collecting data for an economic evalu-
ation was tested by asking participants to complete, at all
assessment points (i.e., baseline, 3 and 6 month follow-
ups), (i) an adapted version of the Client Service Receipt
Fig. 1 CONSORT Flow Diagram
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Inventory (CSRI) [23]; (ii) questions about medicines use;
(iii) EQ-5D-5 L, a general quality of life measure suitable
for calculating QALYs (Quality-adjusted Life-years).
Adherence/competence checks
All sessions were audio-recorded and a random selection
was checked for adherence/competence. Two independ-
ent raters analysed recordings of telephone support ses-
sions of Li-CBT using the Guided CBT Rating Scale [14].
This uses a 3-point scale, ranging from ‘0’ to ‘2’, where ‘1’
corresponds to the minimal acceptable level of compe-
tence/adherence. Two independent raters analysed seg-
ments of recordings of counselling sessions using the
Person-Centred and Experiential Psychotherapy Scale
(PCEPS) [24]. This uses a 10-item, 6-point scale, ranging
from ‘1’ to ‘6’, where ‘3.5’ corresponds to the minimal ac-
ceptable level of competence/adherence.
Statistical analysis
Continuous variables were summarised as mean and
standard deviation (SD). They were compared between
groups using t-tests, and within groups using paired t-
tests. Results of t-tests were reported as mean difference
with 95 % confidence intervals (CIs) and p-values. For
effect sizes, Hedges’ g [25] were given along with 95 %
CIs. All continuous variables were approximately nor-
mally distributed.
Categorical variables were summarised as number and
percentage per group. They were compared between
groups using exact Fisher tests. In reporting effect sizes,
Cramér’s V [26] were given. Recruitment and retention
rates were reported with 95 % (CIs) calculated by the
Clopper and Pearson method [27] with effect sizes, re-
ported using Cohen’s h [28] . All analyses were carried
out in R version 3.0.1 [29].
Results
Primary outcome: recruitment feasibility
Thirty-six eligible and consenting participants were
randomised to one of the two treatments as depicted in
Fig. 1 between February and November 2013. We had
originally aimed to recruit 50 participants to the study.
Demographics of the randomised population are pre-
sented at Table 1.
The overall recruitment rate in relation to screening
packs distributed in the general practice clinics was 36/
1,964 = 1.83 %. The recruitment rate in relation to the
number of screening packs returned (N = 552) was cal-
culated as 6.5 % [4.6, 8.9]. The overall rate of screening
packs returned in relation to the screening packs handed
out was 28.1 %. We received 216 completed question-
naires with reasons for declining participation in the
study (Table 2).
Two participants (one in each arm) withdrew their
participation in the study before they received any treat-
ment. In the PCC arm, participants attended an average
of 5.4 (SD 3.0) counselling sessions and participants in
the Li-CBT arm took part in an average of 5.5 (SD 1.7)
telephone support sessions. Twenty participants com-
pleted the 3-month follow-up assessments (retention
rate 55.6 % [38.1, 72.1]) and 26 participants completed
Fig. 2 GRID-HAMD-17 - Mean and confidence interval for change from baseline at 3-month and at 6-month follow up, by treatment group
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the 6-month follow-up assessments (retention rate
72.2 % [54.8, 85.5]). See Table 3 and Fig. 2.
Compared to baseline, the mean scores on GRID-
HAMD-17 changed significantly at 6 months in both
arms (See Table 4 and Fig. 3). The mean change for the
PCC arm was −8.0 [−11.3, −4.7], p < 0.001, g = 1.57
[0.70, 2.44] and the mean change for the Li-CBT arm
was −7.2 [−0.2, −4.2], p < 0.001,, g = 1.23 [0.38, 2.09].
The between treatment group comparison was not sig-
nificant (mean difference −0.8, p = 0.7).
At 6 months, ten (71.4 %) participants who had a
diagnosis of mild depression at baseline (n = 14) had
recovered; and eight (66.7 %) participants assessed at
6-month follow-up who had a diagnosis of persistent
subthreshold depression at baseline (n = 12) had not
developed major depression (see Table 5). There was
no significant difference between treatment groups for
both recovery (p = 0.7) and prevention of depression at
6 months (p = 1.0).
Compared to baseline, the mean scores on PHQ-9
(depression) and WSAS (social function) changed sig-
nificantly indicating a decrease in depressive symptoms
and an improvement in social and work-related func-
tioning at 6 months (p < 0.001) in both arms, and again
there was no significant difference between treatment
group for both measures (see Tables 6 and 7 and Fig. 4).
The Hedges’ g pre-post effect size for PHQ-9 for the
two groups combined was 1.25 [0.68, 1.82]; the com-
parable Hedges’ g for the WSAS was 1.12 [0.55, 1.69];
both effect sizes are considered 'large' according to
current convention.
Participants’ overall satisfaction with the treatment re-
ceived as measured by the CSQ-8 was high (Mean score
Table 1 Demographics in randomised population
All PCC Li-CBT
N 36 19 17
Age at baseline 44.0 (17.8) 43.3 (15.7) 44.6 (20.4)
Gender Male 6 (16.7 %) 2 (10.5 %) 4 (23.5 %)
Female 30 (83.3 %) 17 (89.5 %) 13 (76.5 %)
Marital status Single/Unmarried 15 (41.7 %) 8 (42.1 %) 7 (41.2 %)
Married/Partnership 14 (38.9 %) 8 (42.1 %) 6 (35.3 %)
Separated/Divorced 3 (8.3 %) 2 (10.5 %) 1 (5.9 %)
Widow/Widower 4 (11.1 %) 1 (5.3 %) 3 (17.6 %)
Education Secondary 6 (17.6 %) 2 (11.8 %) 4 (23.5 %)
Higher/Further 25 (73.5 %) 13 (76.5 %) 12 (70.6 %)
Other 3 (8.8 %) 2 (11.8 %) 1 (5.9 %)
Ethnic group White 35 (97.2 %) 18 (94.7 %) 17 (100.0 %)
Asian 1 (2.8 %) 1 (5.3 %) 0 (0.0 %)
Living situation Alone 9 (25.0 %) 4 (21.1 %) 5 (29.4 %)
Partner 8 (22.2 %) 5 (26.3 %) 3 (17.6 %)
Children 6 (16.7 %) 5 (26.3 %) 1 (5.9 %)
Partner and Children 5 (13.9 %) 2 (10.5 %) 3 (17.6 %)
Other 8 (22.2 %) 3 (15.8 %) 5 (29.4 %)
Employment status Paid or self employment 20 (62.5 %) 12 (66.7 %) 8 (57.1 %)
Unemployed 4 (12.5 %) 2 (11.1 %) 2 (14.3 %)
Housewife/husband 1 (3.1 %) 1 (5.6 %) 0 (0.0 %)
Retired 5 (15.6 %) 3 (16.7 %) 2 (14.3 %)
Exempt through disability 2 (6.2 %) 0 (0.0 %) 2 (14.3 %)
Data summarised as mean (standard deviation) or number (percent) per category
Table 2 Reasons for declining participation - numbers and
percentage of all who declined (N = 216)
Reason N (%)
None ticked 5 (2.3 %)
No low mood or depression 171 (79.2 %)
Too busy 58 (26.9 %)
Does not want to take part in research study 62 (28.7 %)
Does not want to have counselling 69 (31.9 %)
Does not want to have guided CBT 57 (26.4 %)
Other 13 (6.0 %)
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25.8, S 6.7, N = 22), (range of the instrument: 8–32). The
mean CSQ-8 score for participants in the Li-CBT arm
was 27.8 (SD 6.4, N = 13) and for participants in the
PCC arm was 22.9 (SD 6.4, N = 9), p = 0.093.
Economic analysis
EQ-5D-5 L showed a pattern of change consistent with
the depression-specific instruments (PHQ-9 and GRID-
HAMD-17), with scores above normal at baseline but
close to normal at 3 and 6 months (See Table 8). The
data collected with the modified CSRI form showed the
expected phenomenon of outlying values. In the CSRI
question ‘Have you used any of these services in the last
3 months?’, none of the respondents reported any con-
tacts with social workers, psychologists, psychiatrists,
community support workers, and mental health nurses.
In relation to the question ‘Please list below any drugs
taken over the past one month’, of all medicines listed,
only 6.6 % were medicines prescribed for depression
and/or low mood.
Adherence/competence checks
For the Li-CBT arm, 60 % of the support workers had a
sample of their sessions checked for adherence/compe-
tence. The mean score for all rated sessions in the
Guided CBT Rating Scale was 1.50 (N = 8; SD 0.14;
range: 1.20–1.67), corresponding to an acceptable level
of competence/adherence. In the PCC arm there were
five counsellors. Four (80 %) of the counsellors had a
sample of their sessions checked for adherence/compe-
tence. One counsellor fell below the minimal level of
competence/adherence, obtaining a mean score of 2.89
on the PCEPS. This counsellor delivered the interven-
tion to three participants in the study. The mean score
for the rated sessions of the other three counsellors was
4.23 (SD 0.41; range: 3.79 - 4.86), which corresponds to
an acceptable level of competence/adherence.
Discussion
The evidence base for counselling and low-intensity
CBT interventions for sub-threshold depressive symp-
toms and mild depression is limited, particularly in rela-
tion to longer-term outcomes. This feasibility/pilot
study is the first step towards the development of a full-
scale comparative trial that could report short and long-
term outcomes (including cost-effectiveness) of these
interventions.
Recruitment of patients into studies of depression is a
well-documented challenge [30]; therefore the information
Table 3 Retention rates (in %) at 3 and 6 months, with 95 % confidence intervals and p-values comparing randomised groups from
Fisher’s Exact Test
All Randomised Group p-value Cohen's
h
PCC Li-CBT
3-month follow-up retention rate 55.6 (38.1, 72.1) 42.1 (20.3, 66.5) 70.6 (44.0, 89.7) p = 0.106 −0.583
6-month follow-up retention rate 72.2 (54.8, 85.8) 68.4 (43.4, 87.4) 76.5 (50.1, 93.2) p = 0.717 −0.181
Table 4 GRID-HAMD-17. Data summaries at baseline, 3 and 6 months
All Randomised Group Between-group difference
(Li-CBT – PCC)
PCC Li-CBT
Baseline
Mean (SD) 14.7 (4.8) 16.1 (4.1) 13.2 (5.1)
3 months
Mean (SD) 9.5 (6.5) 12.2 (8.0) 7.7 (4.8)
Change from baseline Estimate (95 % CI) −4.7 (−7.4, −2.0) −3.2 (−8.8, 2.3) −5.7 (−8.8, −2.5) 2.4 (−3.6, 8.4)
Hedges' g Estimate (95 % CI) 0.94 (0.35, 1.54) 0.67 (−0.26, 1.59) 1.09 (0.23, 1.95) 0.41 (−0.61, 1.43)
p-value p = 0.001 p = 0.211 p = 0.002 p = 0.398
6 months
Mean (SD) 7.7 (5.1) 8.8 (5.0) 6.7 (5.2)
Change from baseline Estimate (95 % CI) −7.6 (−9.7, −5.5) −8.0 (−11.3, −4.7) −7.2 (−10.2, −4.2) −0.8 (−5.1, 3.4)
Hedges' g Estimate (95 % CI) 1.40 (0.82, 1.98) 1.57 (0.70, 2.44) 1.23 (0.38, 2.09) −0.16 (−1.00, 0.69)
p-value p < 0.001 p < 0.001 p < 0.001 p = 0.684
Estimated changes from baseline at each follow-up visit, on original scale and as effect sizes (Hedge’s g) with 95 % confidence intervals and p-values from paired
t-tests. Estimated between-group differences at each follow-up point with 95 % confidence intervals and p-values from two-sample t-tests of changes
from baseline
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about recruitment, adherence and retention rates obtained
in this study is useful in designing a full-scale randomised
controlled trial. This study demonstrated that the method
of recruitment used was costly in terms of time and effort,
and it did not achieve its recruitment target of 50 patients.
Only 36 patients were recruited to the study via 1964
screening packs distributed. The adherence rates for pa-
tients who began treatment were good and the follow-up/
retention rate at six months was similar to the follow-up
rate at this time in other studies [31, 32]. However, for a
definitive RCT, we would recommend utilising wider re-
cruitment methods, such as notices in local media sites
and routes for self-referral.
On the other hand, our findings suggest that both
PCC and Li-CBT are associated with large reductions in
persistent subthreshold and mild depression. Pre-post
effect sizes for the GRID-HAMD-17 at 3- and 6-month
follow-up ranged from 0.67 to 1.57. However, a com-
parative study would need to be powered to detect
much smaller between-group differences, whether de-
signed to show equivalence/non-inferiority or superior-
ity. A realistic differential effect size for a definitive trial
would be 0.3, which would require a sample size of 235
per group. In this study, we achieved 70 % follow-up at
6 months, implying that approximately 670 participants
would have to be randomised.
Fig. 3 PHQ - Mean and confidence interval for change from baseline at 3-month and at 6-month follow up, by treatment group
Table 5 Diagnosis at 6-month follow up, overall and in relation to diagnosis at baseline, with p-values comparing randomised
groups from Fisher’s Exact Test
All Randomised Group p-value Cramér's
V
PCC Li-CBT
Diagnosis in those with major
depressive episode at baseline
Neither Persistent subthreshold
depression Major depressive episode
10 (71.4 %) 6 (66.7 %) 4 (80.0 %) p = 0.760 F 0.28
2 (14.3 %) 2 (22.2 %) 0 (0.0 %)
2 (14.3 %) 1 (11.1 %) 1 (20.0 %)
Diagnosis in those with persistent
subthreshold depression at baseline
Neither Persistent subthreshold
depression Major depressive episode
8 (66.7 %) 2 (50.0 %) 6 (75.0 %) p = 1.000 F 0.20
2 (16.7 %) 1 (25.0 %) 1 (12.5 %)
2 (16.7 %) 1 (25.0 %) 1 (12.5 %)
Diagnosis in all Neither Persistent subthreshold
depression Major depressive episode
18 (69.2 %) 8 (61.5 %) 10 (76.9 %) p = 0.832 F 0.18
4 (15.4 %) 3 (23.1 %) 1 (7.7 %)
4 (15.4 %) 2 (15.4 %) 2 (15.4 %)
FFisher-test
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In relation to the economic evaluation, the data col-
lected with the modified CSRI could be reduced for a
full-scale RCT, without losing any meaningful detail.
EQ-5D-5 L was sufficiently responsive to change indicat-
ing that it could be used in a definitive RCT.
The involvement of the voluntary sector in delivering
the telephone support for the Li-CBT was innovative
and provided valuable experience of working with this
sector that can be utilised in future studies and health
service interventions. Adherence/competence checks
were successfully carried out in a sample of recordings
of sessions for each treatment by independent raters.
Problems with adherence/competence in the PCC condi-
tion underscore the importance of checking adherence. In
a larger, definitive trial, we would check adherence early
on during the delivery of the interventions to assess the
need for further training.
A two-arm design was adopted rather than a three-
armed study with a control (treatment as usual) condition
after discussion with the funder who recommended that a
two–arm study would have lower cost and more power to
compare the relative cost-effectiveness of the interventions.
Table 6 PHQ-9. Data summaries at baseline, 3 and 6 months
All Randomised Group Between-group difference
(Li-CBT – PCC)
PCC Li-CBT
Baseline
Mean (SD) 12.8 (5.2) 15.2 (4.0) 10.2 (5.2)
3 months
Mean (SD) 7.5 (5.7) 10.9 (7.1) 5.2 (3.3)
Change from baseline Estimate (95 % CI) −5.0 (−7.2, −2.7) −3.8 (−8.3, 0.8) −5.8 (−8.5, −3.0) 2.0 (−3.0, 7.0)
Hedges' g Estimate (95 % CI) 0.97 (0.37, 1.57) 0.82 (−0.11, 1.76) 1.06 (0.20, 1.91) 0.40 (−0.62, 1.42)
p-value p < 0.001 p = 0.092 p = 0.001 p = 0.401
6 months
Mean (SD) 6.0 (5.7) 7.5 (6.0) 4.4 (5.1)
Change from baseline Estimate (95 % CI) −7.4 (−9.8, −5.1) −8.2 (−11.7, −4.7) −6.6 (−10.3, −3.0) −1.6 (−6.4, 3.2)
Hedges' g Estimate (95 % CI) 1.25 (0.68, 1.82) 1.51 (0.65, 2.38) 1.09 (0.25, 1.93) −0.26 (−1.11, 0.58)
p-value p < 0.001 p < 0.001 p = 0.002 p = 0.493
Estimated changes from baseline at each follow-up visit, on original scale and as effect sizes (Hedge’s g) with 95 % confidence intervals and p-values from paired
t-tests. Estimated between-group differences at each follow-up point with 95 % confidence intervals and p-values from two-sample t-tests of changes
from baseline
Table 7 WSAS. Data summaries at baseline, 3 and 6 months
All Randomised Group Between-group difference
(Li-CBT – PCC)
PCC Li-CBT
Baseline
Mean (SD) 16.9 (6.8) 18.3 (7.1) 15.2 (6.2)
3 months
Mean (SD) 11.9 (7.2) 13.6 (5.9) 10.8 (8.1)
Change from baseline Estimate (95 % CI) −4.8 (−7.3, −2.2) −5.4 (−11.3, 0.5) −4.3 (−7.3, −1.4) −1.0 (−7.2, 5.2)
Hedges' g Estimate (95 % CI) 0.70 (0.11, 1.28) 0.67 (−0.25, 1.60) 0.61 (−0.21, 1.43) −0.18 (−1.19, 0.84)
p-value p = 0.001 p = 0.067 p = 0.008 p = 0.719
6 months
Mean (SD) 8.7 (7.7) 8.8 (4.9) 8.7 (10.2)
Change from baseline Estimate (95 % CI) −9.1 (−12.3, −5.8) −10.4 (−15.4, −5.4) −7.6 (−12.5, −2.7) −2.8 (−9.3, 3.8)
Hedges' g Estimate (95 % CI) 1.12 (0.55, 1.69) 1.47 (0.61, 2.33) 0.79 (−0.05, 1.62) −0.33 (−1.20, 0.54)
p-value p < 0.001 p = 0.001 p = 0.006 p = 0.395
Estimated changes from baseline at each follow-up visit, on original scale and as effect sizes (Hedge’s g) with 95 % confidence intervals and p-values from paired
t-tests. Estimated between-group differences at each follow-up point with 95 % confidence intervals and p-values from two-sample t-tests of changes
from baseline
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In retrospect, the lack of a control group was a weakness
of this study since it was possible that improvement in ei-
ther or both arms reflected the impact of time, usual care
or other factors. Therefore, we recommend that for a full-
scale RCT, a usual care arm be offered to address the ques-
tion of what level of improvement would occur over time
with no additional active intervention being offered. An
added advantage is that this would allow usual care to be
described in detail.
Conclusions
This pilot study has provided important information for
the design of a full-scale randomised controlled trial. A
key question from the current study is how to detect
and then support people whose symptoms are at such a
low level that their motivation to engage and complete
treatment may be low. We found that it is possible to
detect potential participants; however this required sig-
nificant input at the GP surgery. We also found that it
Fig. 4 WSAS - Mean and confidence interval for change from baseline at 3-month and at 6-month follow up, by treatment group
Table 8 EQ-5D-5 L. Data summaries at baseline, 3 and 6 months
All Randomised Group Between-group difference
(Li-CBT – PCC)
PCC Li-CBT
Baseline
Mean (SD) 0.67 (0.21) 0.66 (0.19) 0.69 (0.23)
3 months
Mean (SD) 0.76 (0.13) 0.77 (0.10) 0.75 (0.15)
Change from baseline Estimate (95 % CI) 0.09 (0.04, 0.15) 0.13 (0.01, 0.24) 0.07 (0.00, 0.14) 0.05 (−0.07, 0.18)
Hedges' g Estimate (95 % CI) −0.43 (−1.01, 0.14) −0.58 (−1.50, 0.34) −0.30 (−1.11, 0.51) 0.42 (0.60, 1.44)
p-value p = 0.003 p = 0.032 p = 0.049 p = 0.369
6 months
Mean (SD) 0.75 (0.17) 0.79 (0.10) 0.70 (0.22)
Change from baseline Estimate (95 % CI) 0.12 (0.05, 0.18) 0.16 (0.05, 0.28) 0.07 (−0.01, 0.15) 0.10 (−0.04, 0.23)
Hedges' g Estimate (95 % CI) −0.37 (−0.89, 0.16) −0.78 (−1.56, 0.01) −0.07 (−0.85, 0.71) 0.57 (−0.29, 1.43)
p-value p = 0.001 p = 0.007 p = 0.095 p = 0.146
Estimated changes from baseline at each follow-up visit, on original scale and as effect sizes (Hedge’s g) with 95 % confidence intervals and p-values from paired
t-tests. Estimated between-group differences at each follow-up point with 95 % confidence intervals and p-values from two-sample t-tests of changes
from baseline
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was possible to successfully deliver interventions using
PCC or Li-CBT. The evidence from this study suggests
that short-term Person-Centred Counselling and Low
Intensity Cognitive Behavioural Therapy are potentially
effective with this client population and that their effect-
iveness should be subject to a larger randomised con-
trolled study.
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